Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
Curis Lifesciences Limited IPO
₹ 256000 / 2000 Shares Shares
Minimum Investment
Curis Lifesciences Limited IPO
Issues Price
₹120-128 per equity share
Curis Lifesciences Limited IPO
Open Date
07 Nov 2025
Close Date
11 Nov 2025
Lot Size
1000
Min. Investment
₹ 256000
Issue Price
₹120-128
Listing Date
14 Nov 2025
Issues Size
21,50,000 shares(aggregating up to ₹27.52 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
2000 Shares
Offered To Public
2000 Shares
Curis Lifesciences Limited IPO
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
Founded In
2020
Managing Director
Dharmesh Dasharathbhai Patel
Parent Organization
Curis Lifesciences Limited IPO
Application for Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I used to avoid NFOs due to uncertainty. KSquare’s clear data and investor tools changed my mind. Now, I feel fully informed and prepared.
I was impressed by how seamless KSquare’s NRI services are. They handled my documentation with care and helped me invest without unnecessary hassle.
KSquare’s NRI Corner made investing from abroad incredibly simple. The guidance was crystal clear, and their support team always kept me informed. Highly recommend this service for all NRIs!
I was skeptical about loans on mutual funds, but KSquare provided full clarity and fast execution. Loved the experience!
For long-term stability, I trust KSquare’s NPS guidance. Their regular insights and personal approach are top-notch.
The fund selection process at KSquare is simple yet thorough. Their insights helped me diversify properly and reduce risk effectively. Very pleased!
Navigating investments from Canada was overwhelming until I used KSquare’s NRI services. They simplified the entire process beautifully.
KSquare gave me confidence to grow wealth in India from abroad. The onboarding was smooth, and they guided me at every step.
My dream vacation finally happened through planned SIP savings with KSquare. They track progress regularly and make sure goals never slip. A wonderful financial planning experience for every family.
KSquare’s SIP plans make long-term investing easier than ever. I set up my account in minutes and now watch my portfolio grow every month.
FAQ's
Frequenlty Asked Question
Why should I choose KSquare over other platforms for NRI investing?
KSquare offers tailored advice, easy KYC, global access, compliance support, and personal service for NRI investors.
Do I need a demat account to apply for this loan?
Yes, most lenders require mutual fund units in demat form. KSquare can help convert physical units if needed.
Can I nominate someone for my NPS account?
Yes, nomination is mandatory and can be easily added or updated through your KSquare profile.
Is NPS better than PPF or EPF for retirement?
NPS can offer higher returns due to market exposure, while PPF and EPF are safer but lower-yielding. It’s best to diversify.
What’s the minimum investment required in an NFO?
Most NFOs start with a minimum investment of ₹500 or ₹1,000. KSquare clearly shows these details for each offering.
Is NPS a market-linked investment?
Yes, NPS invests in equity and debt instruments, so returns vary with market performance over time.
Is there a credit score requirement for getting LAMF?
While credit score matters, lenders also consider the value and type of mutual funds pledged. KSquare helps assess your eligibility beforehand.
What is a Loan Against Mutual Fund (LAMF)?
A Loan Against Mutual Fund allows you to borrow money by pledging your mutual fund units as collateral without selling your investments.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.